PMID- 19805359 OWN - NLM STAT- MEDLINE DCOM- 20091228 LR - 20211020 IS - 1091-6490 (Electronic) IS - 0027-8424 (Print) IS - 0027-8424 (Linking) VI - 106 IP - 39 DP - 2009 Sep 29 TI - Central role of TRAF-interacting protein in a new model of brain sexual differentiation. PG - 16692-7 LID - 10.1073/pnas.0906293106 [doi] AB - Sexually dimorphic brain nuclei underlie gender-specific neural functions and susceptibility to disease, but the developmental basis of dimorphisms is poorly understood. In these studies, we focused on the anteroventral periventricular nucleus (AVPV), a nucleus that is larger in females and critical for the female-typical cyclic surge pattern of luteinizing hormone (LH) release. Sex differences in the size and function of the AVPV result from apoptosis that occurs preferentially in the developing male. To identify upstream pathways responsible for sexual differentiation of the AVPV, we used targeted apoptosis microarrays and in vivo and in vitro follow-up studies. We found that the tumor necrosis factor alpha (TNFalpha)-TNF receptor 2 (TNFR2)-NFkappaB cell survival pathway is active in postnatal day 2 (PND2) female AVPV and repressed in male counterparts. Genes encoding key members of this pathway were expressed exclusively in GABAergic neurons. One gene in particular, TNF receptor-associated factor 2 (TRAF2)-inhibiting protein (trip), was higher in males and it inhibited both TNFalpha-dependent NFkappaB activation and bcl-2 gene expression. The male AVPV also had higher levels of bax and bad mRNA, but neither of these genes was regulated by either TNFalpha or TRIP. Finally, the trip gene was not expressed in the sexually dimorphic nucleus of the preoptic area (SDN-POA), a nucleus in which apoptosis is higher in females than males. These findings form the basis of a new model of sexual differentiation of the AVPV that may also apply to the development of other sexually dimorphic nuclei. FAU - Krishnan, Sudha AU - Krishnan S AD - Department of Biology, University of Massachusetts-Amherst, 611 North Pleasant Street, Amherst, MA 01003, USA. FAU - Intlekofer, Karlie A AU - Intlekofer KA FAU - Aggison, Leah K AU - Aggison LK FAU - Petersen, Sandra L AU - Petersen SL LA - eng GR - R01 HD027305/HD/NICHD NIH HHS/United States GR - R21 ES013885/ES/NIEHS NIH HHS/United States GR - HD 027305/HD/NICHD NIH HHS/United States GR - ES 013885/ES/NIEHS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20090917 PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (NF-kappa B) RN - 0 (TNF Receptor-Associated Factor 2) RN - 0 (Tumor Necrosis Factor Receptor-Associated Peptides and Proteins) RN - 0 (Tumor Necrosis Factor-alpha) RN - 56-12-2 (gamma-Aminobutyric Acid) SB - IM MH - Animals MH - Anterior Hypothalamic Nucleus/metabolism MH - Brain/*physiology MH - Female MH - Genes, bcl-2 MH - Male MH - Models, Biological MH - NF-kappa B/genetics/metabolism MH - Neurons/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - *Sex Differentiation MH - TNF Receptor-Associated Factor 2/genetics/metabolism MH - Tumor Necrosis Factor Receptor-Associated Peptides and Proteins/genetics/*metabolism MH - Tumor Necrosis Factor-alpha/genetics/metabolism MH - gamma-Aminobutyric Acid/metabolism PMC - PMC2757835 COIS- The authors declare no conflict of interest. EDAT- 2009/10/07 06:00 MHDA- 2009/12/29 06:00 PMCR- 2010/03/29 CRDT- 2009/10/07 06:00 PHST- 2009/10/07 06:00 [entrez] PHST- 2009/10/07 06:00 [pubmed] PHST- 2009/12/29 06:00 [medline] PHST- 2010/03/29 00:00 [pmc-release] AID - 0906293106 [pii] AID - 9694 [pii] AID - 10.1073/pnas.0906293106 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16692-7. doi: 10.1073/pnas.0906293106. Epub 2009 Sep 17.